Preservative-free bimatoprost 0.03%/timolol 0.5% fixed combination in patients with glaucoma in clinical practice

PURPOSE: The aim of this study was to evaluate the efficacy and tolerability of, and compliance to, preservative-free (PF), fixed-combination (FC) bimatoprost 0.03%/timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension in a clinical practice setting. PATIENTS AND METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Pfennigsdorf, Stefan, Eschstruth, Peter, Häsemeyer, Stefan, Feuerhake, Cord, Brief, Gerrett, Grobeiu, Ioana, Shirlaw, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Clinical Trial Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5036566/
https://www.ncbi.nlm.nih.gov/pubmed/27703324
http://dx.doi.org/10.2147/OPTH.S106159

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5036566/
https://www.ncbi.nlm.nih.gov/pubmed/27703324
http://dx.doi.org/10.2147/OPTH.S106159

Ejemplares similares